Patentability of Genetically Modified Plant Breeds: The Monsanto Conclusion

The Supreme Court of India’s Monsanto judgment addresses the complex issue of patentability for genetically modified plant breeds. By remanding the case for evidence-based adjudication, the Court reinforces procedural rigour in intellectual property disputes involving agricultural biotechnology.

Read more about Patentability of Genetically Modified Plant Breeds: The Monsanto Conclusion

Interesting inventions, National Intellectual Property Awards 2019, Patent Infringement news, USPTO shutdown and more

The post delivers a structured account of Indian patent statistics, notable inventions, and intellectual property awards, alongside significant patent infringement legal news. It also covers international developments, including USPTO operations and Japanese patent law changes.

Read more about Interesting inventions, National Intellectual Property Awards 2019, Patent Infringement news, USPTO shutdown and more

Abbott’s HIV Drug Patent “Not an Invention”

The Indian Patent Office has rejected Abbott’s application for an HIV drug patent, finding no inventive step in the claimed composition. This decision highlights the robust scrutiny applied to pharmaceutical patents in India and the importance of pre grant opposition in safeguarding public health interests.

Read more about Abbott’s HIV Drug Patent “Not an Invention”